10M€ raised through a private placement
19/08/2019 – AB Science announces the success of a private placement
19/08/2019 – AB Science announces the success of a private placement
12/08/2019 – AB science will present a corporate overview at two upcoming healthcare conferences in September 2019, in New York.
05/08/2019 – AB Science provides an update on its masitinib clinical program.
02/08/2019 – AB Science reports the analysis for its phase 3 trial evaluating masitinib in patients with non-resectable or metastatic stage 3 or stage 4 melanoma.